Table 2.
Demographic and laboratory data of the study participants regarding the presence of insulin resistance
| Patients with insulin resistance (HOMA-IR >2.7)n = 35 | Patients without insulin resistance (HOMA-IR<2.7)n = 46 | p | |
|---|---|---|---|
| Age, years | 38.1±10.6 | 35.7±9.2 | 0.279 |
| Male/female | 17/18 | 23/23 | ns |
| BMI | 29.4±5.3 | 28.1±4.8 | ns |
| Adropin, pg/mL | 600±271 | 778±323 | 0.010 |
| Glucose, mg/dL | 96.5±9.4 | 88.7±9.4 | <0.001 |
| Insulin, µIU/mL | 22.8±12.2 | 7.6±2.3 | <0.001 |
| Total cholesterol, mg/dL | 208.5±38.5 | 198.7±44.1 | 0.299 |
| HDL-C, mg/dL | 47.7±13.9 | 46.6±13.9 | 0.746 |
| LDL-C, mg/dL | 131±33.8 | 123±41.5 | 0.372 |
| Triglyceride, mg/dL | 145±44.4 | 142±62.3 | 0.836 |
| Urea, mg/dL | 35.02±15.5 | 28.9±12.1 | 0.051 |
| Creatinine, mg/dL | 0.77±0.16 | 0.72±0.18 | 0.235 |
| AST, IU/L | 25.4±10.7 | 19.4±9.5 | 0.011 |
| ALT, IU/L | 24.6±10.4 | 22.4±22.8 | 0.597 |
| GGT, IU/L | 29.08±19.03 | 20.3±15.6 | 0.025 |
| ALP, IU/L | 77.6±34.9 | 69.1±28.7 | 0.292 |
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; ALP, alkaline phosphatase; HOMA-IR, homeostatic model of assessment-insulin resistance; ns, not significant.